Create
Query
event_store.db
—
signals
actions
agent_runs
approvals
artifacts
attention_candidates
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
intel_narrative_members
intel_narratives
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
×
Could not fetch row with primary-key sig_78f9222558f6.
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_04e1c421d82a in signals
id
sig_04e1c421d82a
Primary key.
TEXT
event_id
468825
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_unusual_volume_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.nasdaq.com/articles/heres-why-agios-pharmaceuticals-crashed-23-today","as_of":"2026-04-20T17:15:12.787981+00:00","canonical_url":"https://www.fool.com/investing/2026/04/20/heres-why-agios-pharmaceuticals-crashed-23-today/","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/heres-why-agios-pharmaceuticals-crashed-23-today","article_chars":3742,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_1684d53a5f2797dd","canonical_host":"fool.com","canonical_is_aggregator":false,"canonical_url":"https://www.fool.com/investing/2026/04/20/heres-why-agios-pharmaceuticals-crashed-23-today/","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-21T03:04:28.614930+00:00","extraction_method":"trafilatura","fetched_description":"Key PointsAgios Pharmaceuticals shares dropped 23% following Novo Nordisk's trial results.","fetched_title":"Here's Why Agios Pharmaceuticals Crashed 23% Today | Nasdaq","final_url":"https://www.nasdaq.com/articles/heres-why-agios-pharmaceuticals-crashed-23-today","html_truncated":false,"paywall_likely":false,"publisher_domain":"fool.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/heres-why-agios-pharmaceuticals-crashed-23-today","source_event_id":"evt_a077a74129d9","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"daa4177d6c22d726","kind":"unusual_volume","published_at":"2026-04-20T16:39:21+00:00","publisher_domain":"fool.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.74,"dates_mentioned":["late 2026","November","second half of 2026","April 20, 2026"],"entities":[{"asset_class":"equity","name":"Agios Pharmaceuticals","relevance":"high","symbol":"AGIO","type":"company"},{"asset_class":"equity","name":"Novo Nordisk","relevance":"high","symbol":"NVO","type":"company"},{"asset_class":"other","name":"etavopivat","relevance":"high","symbol":"","type":"drug"},{"asset_class":"other","name":"mitapavit","relevance":"high","symbol":"","type":"drug"},{"asset_class":"other","name":"FDA","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"price_action","information_gaps":["Unusual volume details are missing: no baseline volume, no volume ratio vs average, and no direction beyond the 23% price drop.","The signal is described as \u201cdiscovery_unusual_volume_delta,\u201d but the provided text does not include any volume metrics or confirmation status for unusual volume.","No explicit statement whether the 23% move is confirmed by additional news sources beyond the article\u2019s attribution to Novo\u2019s trial results.","Catalyst hypothesis for the volume delta cannot be determined from the text because volume data is not provided."],"key_facts":["AGIO shares were down 23% as of 11 a.m. today.","The article attributes the move to Novo Nordisk\u2019s reported results.","Novo\u2019s etavopivat met both co-primary endpoints in the Phase 3 HIBISCUS trial, according to Novo\u2019s release.","The article states Novo plans to file for FDA approval in late 2026.","The article contrasts Agios\u2019 Phase 3 mitapavit results released in November, stating it did not show a statistically significant improvement in its primary endpoint (annualized rate of sickle cell pain crises) versus placebo.","The article says Novo reported \u201ctime to first\u201d VOC of 38.4 weeks in the treatment group vs 20.9 weeks in the placebo group.","The article characterizes Novo\u2019s intent to file as a threat to Agios\u2019 earnings potential and describes Agios\u2019 path to approval as longer and more uncertain."],"numeric_claims":[{"label":"AGIO price drop","value":"23% (as of 11 a.m. today)"},{"label":"Time to first VOC (Novo etavopivat)","value":"38.4 weeks"},{"label":"Time to first VOC (placebo)","value":"20.9 weeks"}],"primary_claim":"Agios Pharmaceuticals shares dropped 23% as of 11 a.m. today following Novo Nordisk\u2019s Phase 3 trial results for etavopivat.","relevance_score":0.78,"sentiment":"negative","source_quality":"high","summary":"Agios Pharmaceuticals (NASDAQ: AGIO) fell about 23% intraday after Novo Nordisk reported Phase 3 results for etavopivat in sickle cell disease. The article frames Novo\u2019s data and planned late-2026 FDA filing as a threat to Agios\u2019 mitapavit market potential.","topics":["sickle cell disease","Phase 3 trial results","etavopivat vs mitapavit","FDA approval timeline","stock price move"]},"source":"Nasdaq Markets","source_domain":"fool.com","summary":"Key PointsAgios Pharmaceuticals shares dropped 23% following Novo Nordisk's trial results.","tickers":[],"title":"Here's Why Agios Pharmaceuticals Crashed 23% Today","url":"https://www.fool.com/investing/2026/04/20/heres-why-agios-pharmaceuticals-crashed-23-today/"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_ingestor
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_a077a74129d9"]}
TEXT
dedupe_key
signal_enriched:discovery_unusual_volume_delta:db7913757d01ff38
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-20T17:15:12.787981+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel